dapiprazole and Eye-Diseases

dapiprazole has been researched along with Eye-Diseases* in 1 studies

Reviews

1 review(s) available for dapiprazole and Eye-Diseases

Article	Year
Dapiprazole: will it affect the standard of care for pupillary dilation? Optometry clinics : the official publication of the Prentice Society, 1992, Volume: 2, Issue:4 One of the most controversial clinical issues in optometry is the use of "routine" pupillary dilation. Many optometrists are still reluctant to employ routine dilation because of concerns regarding patient inconvenience, angle-closure glaucoma, or systemic side effects. Dapiprazole, a new alpha-adrenergic blocking agent, is now available to reverse the effects of tropicamide- or phenylephrine-induced mydriasis. This article discusses the advantages, clinical uses, limitations, and legal aspects of this mydriatic antagonist in optometric practice. Topics: Adrenergic alpha-Antagonists; Eye Diseases; Humans; Mydriatics; Phenylephrine; Piperazines; Pupil; Triazoles; Tropicamide	1992

Article

Year

Dapiprazole: will it affect the standard of care for pupillary dilation?

Optometry clinics : the official publication of the Prentice Society, 1992, Volume: 2, Issue:4

One of the most controversial clinical issues in optometry is the use of "routine" pupillary dilation. Many optometrists are still reluctant to employ routine dilation because of concerns regarding patient inconvenience, angle-closure glaucoma, or systemic side effects. Dapiprazole, a new alpha-adrenergic blocking agent, is now available to reverse the effects of tropicamide- or phenylephrine-induced mydriasis. This article discusses the advantages, clinical uses, limitations, and legal aspects of this mydriatic antagonist in optometric practice.

Topics: Adrenergic alpha-Antagonists; Eye Diseases; Humans; Mydriatics; Phenylephrine; Piperazines; Pupil; Triazoles; Tropicamide

1992